Correlation Between Appili Therapeutics and Medicenna Therapeutics

Can any of the company-specific risk be diversified away by investing in both Appili Therapeutics and Medicenna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Appili Therapeutics and Medicenna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Appili Therapeutics and Medicenna Therapeutics Corp, you can compare the effects of market volatilities on Appili Therapeutics and Medicenna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Appili Therapeutics with a short position of Medicenna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Appili Therapeutics and Medicenna Therapeutics.

Diversification Opportunities for Appili Therapeutics and Medicenna Therapeutics

0.02

Correlation Coefficient

Appili Therapeutics  Medicenna Therapeutics

Significant diversification

The 3 months correlation between Appili and Medicenna is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Appili Therapeutics and Medicenna Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicenna Therapeutics and Appili Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Appili Therapeutics are associated (or correlated) with Medicenna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicenna Therapeutics has no effect on the direction of Appili Therapeutics i.e., Appili Therapeutics and Medicenna Therapeutics go up and down completely randomly.

Pair Corralation between Appili Therapeutics and Medicenna Therapeutics

Assuming the 90 days trading horizon Appili Therapeutics is expected to generate 1.42 times more return on investment than Medicenna Therapeutics. However, Appili Therapeutics is 1.42 times more volatile than Medicenna Therapeutics Corp. It trades about -0.12 of its potential returns per unit of risk. Medicenna Therapeutics Corp is currently generating about -0.26 per unit of risk. If you would invest  3.50  in Appili Therapeutics on October 12, 2024 and sell it today you would lose (0.50) from holding Appili Therapeutics or give up 14.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Appili Therapeutics  vs.  Medicenna Therapeutics Corp

Appili Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Appili Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Appili Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Medicenna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Appili Therapeutics and Medicenna Therapeutics

The main advantage of trading using opposite Appili Therapeutics and Medicenna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Appili Therapeutics position performs unexpectedly, Medicenna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics will offset losses from the drop in Medicenna Therapeutics' long position.

The idea behind Appili Therapeutics and Medicenna Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.